Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PH | GEV |
|---|---|---|
| Price | $969.39 | $951.57 |
| Change today | ▼ 0.19% | ▼ 0.03% |
| Market cap | $122.25B | $253.44B |
| Return, 3 months | +1.1% | -10.0% |
| Return, year to date | +11.0% | +45.9% |
| Return, 1 year | +30.5% | +51.6% |
| P/E (TTM) | 34.0 | 27.3 |
| P/B | 7.9 | 21.2 |
| P/E percentile vs own 5y | 79th | 13th |
| Dividend yield | 0.76% | 0.21% |
| Revenue growth (YoY, latest qtr) | +9.8% | +21.9% |
| Net profit growth (YoY) | +18.3% | +31.9% |
| Gross margin | 37.7% | 20.2% |
| Operating margin | 21.6% | 4.4% |
| Net margin | 17.0% | 23.0% |
| Return on equity | 25.1% | 91.5% |
| Analyst target vs. price | +24.5% | +31.3% |
| Analyst buy share | 77% | 89% |
| RSI (14) | 53 | 49 |
| 30-day volatility | 22.6% | 47.5% |
| Max drawdown, 1 year | -19.3% | -25.5% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.